Latest News & Features
Europe
In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil of Marks & Clerk explore what this pivot means for applicants protecting their AI technology. 9 April 2026
Careers
The firm has added two partners to its government and regulatory team, bringing expertise in FDA matters, product approvals, and regulatory risk. 9 April 2026
Biotechnology
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments. 8 April 2026
Biotechnology
On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering. 7 April 2026
Americas
According to the settlement, MSN can maintain its challenge to several Bausch patents, while the details around potential product launch timings are unknown. 7 April 2026
Europe
Two of Europe’s most important IP offices have implemented fee increases this month, with some long-standing UK charges, dating back to the late 1990s, finally seeing a rise. 2 April 2026
Europe
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal. 2 April 2026
Americas
After years of strict patent rules, Argentina is changing course. New IP reforms are putting the country back on the map, but how companies handle the transition will matter. 1 April 2026
Asia
The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar. 31 March 2026
Europe
Judges found no reason to set aside provisional measures issued by a local division, following a challenge from Sinocare and A Menarini Diagnostics. 30 March 2026